Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric Carcinoma

NCT00881816 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Nanjing Sike Pharmaceutical Co., Ltd.